| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |